- Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid LeukemiaZha, Jie; Wang, Ying; Li, Zhenling; Lin, Zhijuan; Cai, Yun; Gong, Tiejun; Md, Wei Yang; Xie, Siting; Huang, Zhenqi; Shi, Pengcheng; Fu, Lin; Wang, Jinghua; Fu, Xiangjun; Feng, Xianqi; Su, Liping; Luo, Jianmin; Yang, Lin; Chen, Biyun; Xie, Ying; Zhu, Yu; Du, Xin; Jiang, Yirong; Li, Zhifeng; Xu, Bing65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.被引 1
- Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid LeukemiaZha, Jie; Zhou, Hui; Zhong, Mengya; Wang, Ying; Du, Xin; Gong, Tiejun; Lin, Zhijuan; Cai, Yun; Xie, Siting; Xie, Chendi; Feng, XianQi; Huang, ZhenQi; Su, Liping; Luo, Jianmin; Yang, Lin; Li, Zhenling; Chen, Bi-yun; Xie, Ying; Zhu, Yu; Shi, Pengcheng; Li, Zhifeng; Jiang, Yirong; Xu, Bing64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.被引 2
- Efficacy and Safety Analysis of Venetoclax Combined with Azacitidine in Real-World Treatment of Patients with AMLHuang, Xin; Deng, Chengxin; Li, Minming; Lu, Zesheng; Wu, Ping; Luo, Qiong; Geng, Suxia; Zeng, Lingji; Wang, Yulian; Zhou, Hui; Weng, Jianyu; Du, Xin65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
会议论文
Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
15阅读
